Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

CYP3A5 is the primary CYP3A subfamily enzyme expressed in the human kidney and its aberrant expression may contribute to a broad spectrum of renal disorders. Pharmacogenetic studies have reported inconsistent linkages between CYP3A5 expression and hypertension, however, most investigators have consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lidberg, Kevin A., Annalora, Andrew J., Jozic, Marija, Elson, Daniel J., Wang, Lu, Bammler, Theo K., Ramm, Susanne, Monteiro, Maria Beatriz, Himmelfarb, Jonathan, Marcus, Craig B., Iversen, Patrick L., Kelly, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907328/
https://www.ncbi.nlm.nih.gov/pubmed/33633318
http://dx.doi.org/10.1038/s41598-021-84194-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907328/
https://www.ncbi.nlm.nih.gov/pubmed/33633318
http://dx.doi.org/10.1038/s41598-021-84194-w

Ejemplares similares